After AI express, investors ask questions on the investor interaction platform: Hello, there are several vaccine products and several monoclonal antibody drug products in the company. The company’s pulp collection station has not increased in recent years, and the pulp collection volume has been maintained at about 1000 tons. The company may have some difficulty in approving the pulp collection station. So can the company conduct more in-depth research on blood products in the future? At present, the company has only 11 blood products.
Hualan Biological Engineering Inc(002007) (002007. SZ) said on the investor interaction platform on February 26 that at present, there are 7 products of Hualan vaccine and 7 products of Hualan gene are undergoing clinical trials; The company is actively applying to relevant departments for new plasma collection stations.
